A two plasmid co-expression system in Escherichia coli for the production of virion-like reverse transcriptase of the human immunodeficiency virus type 1

Journal of Virological Methods

Volumn 61, Issue 1-2, 1996, Pages 113-125

  Jonckheere, Heidi ^a   De Vreese, Karen ^a   Debyser, Zeger ^a   Vandekerckhove, Joël ^b   Balzarini, Jan ^a   Desmyter, Jan ^a   De Clercq, Erik ^a   Anné, Jozef ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Co expression; Drug sensitivity; HIV 1 reverse transcriptase; RT subunits

Indexed keywords

ANTIVIRUS AGENT; ENZYME INHIBITOR; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SPECTROMETRY; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030250001     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(96)02076-9     Document Type: Article

References (33)

1. Balzarini, J., Karlsson, A., Perez-Perez, M.-J. et al. (1993) HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Virology 192, 246-253.
2. Bathurst, I.C., Moen, L.K., Lujan, M.A. et al. (1990) Characterization of the HIV-1 reverse transcriptase enzyme produced in yeast. Biochem. Biophys. Res. Commun. 171, 589-595.
3. Bhikhabhai, R., Carlsson, T., Unge, T., Lövgren, S. and Strandberg, B. (1993) Increased yield of homogeneous HIV-1 reverse transcriptase (p66/p51) using a slow purification approach. J. Chromatogr. 639, 67-74.
4. Boyer, P.L., Ding, J., Arnold, E. and Hughes, S.H. (1994) Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 38, 1909-1914.
5. Chang, Y.C.Y. and Cohen, S.N. (1978) Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the p15A cryptic miniplasmid. J. Bacteriol. 134, 1141-1156.
6. Chandra, A., Gerber, T., Kaul, S., Wolf, C., Demirhan, I. and Chandra P. (1986) Biochemical heterogeneity of reverse transcriptase purified from the AIDS virus. FEBS Lett. 197, 84-88.
7. Chattopadhyay, D., Einspahr, H.M., Brunner, D.P., Strakalaitis, N.A., Tarpley, W.G. and Deibel, M.R. (1992) Resolution of microheterogeneity associated with recombinant HIV-1 heterodimeric reverse transcriptase. Protein Expression Purif. 3, 151-159.
8. D'Aquila, R.T. and Summers, W.C. (1989) HIV-1 reverse transcriptase/ ribonuclease H: high level expression in E.coli from a plasmid constructed using the polymerase chain reaction. J. Acquir. Immune Defic. Syndr. 2, 579-587.
9. Debyser, Z., Pauwels, R., Andries, K. et al. (1992a) Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds. Mol. Pharmacol. 41, 203-208.
10. Debyser, Z., Vandamme, A.-M., Pauwels, R., Baba, M., Desmyter, J. and De Clercq, E. (1992b) Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2′,3′-deoxynucleoside 5′-triphosphate, tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives. J. Biol. Chem. 267, 11769-11776.
11. Debyser, Z., De Vreese, K., Knops-Gerrits, P.P. et al. (1993) Differential kinetics and susceptibilities of mutagenized reverse transcriptases (RT) to HIV-1-specific RT inhibitors. Mol. Pharmacol. 43, 521-526.
12. Deibel, M.R., McQuade, T.J., Brunner, D.P. and Tarpley, W.G. (1990) Denaturation/refolding of purified recombinant HIV reverse transcriptase yields monomeric enzyme with high enzymatic activity. AIDS Res. Hum. Retrovir. 6, 329-340.
13. De Vreese, K., Debyser, Z., Vandamme, A. et al. (1992) Resistance of HIV-1 reverse transcriptase to TIBO-derivates induced by site-directed mutagenesis. Virology 188, 900-904.
14. diMarzo Veronese, F., Copeland, D.T., DeVico, A.L. et al. (1986) Characterization of highly immunogenic p66/p51 as reverse transcriptase of HTLV-III/LAV. Science 231, 1289-1291.
15. Farmerie, W.G., Loeb, D.D., Casavant, N.C. et al. (1987) Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science 236, 305-308.
16. Graves, M.C., Meidel, M.C., Pan, Y.E. et al. (1990) Identification of human immunodeficiency virus-1 protease cleavage site within the 66000 dalton subunit of reverse transcriptase. Biochem. Biophys. Res. Commun. 168, 30-36.
17. Hostomsky, Z., Hostomska, Z., Fu, T. and Taylor, J. (1992) Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis. J. Virol. 66, 3179-3182.
18. Howard, K.J., Frank, K.B., Sim, I.S. and LeGrice, S.F. (1991) Reconstruction and properties of homologous and chimeric HIV-1.HIV-2 p66.p51 reverse transcriptase. J. Biol. Chem. 266, 23003-23009.
19. Jacobo-Molina, A., Ding, J., Nanni, R.G. et al. (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90, 6320-6324.
20. Jacques, P.S., Wöhrl B.M., Howard K.J. and Le Grice S.F.J. (1994) Modulation of HIV-1 reverse transcriptase function in 'selectively deleted' p66/p51 heterodimers. J. Biol. Chem. 269, 1388-1393.
21. Jonckheere, H., Taymans, J.-M., Balzarini, J. et al. (1994) Resistance of HIV-1 reverse transcriptase against TSAO-derivatives is determined by the mutation 138Glu → Lys on the p51 subunit. J. Biol. Chem. 269, 25255-25258.
22. Kohlstaedt, L.A., Wang, J., Friedman, J.M. and Steitz, T.A. (1992) Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783-1790.
23. Le Grice, S.F.J. and Grüninger-Leitch, F. (1990) Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur. J. Biochem. 187, 307-314.
24. Lightfoote, M.M., Coligan, J.E., Folks, T.M., Fauci, A.S., Martin, M.A. and Venkatesan, S. (1986) Structural characterization of reverse transcriptase and endonuclease polypeptides of acquired immune deficiency syndrome retrovirus. J. Virol. 60, 771-775.
25. Lowe, D.M., Aitken, A., Bradly, C., Darby, G.K. et al. (1988) HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis. Biochemistry 27, 8884-8889.
26. Mizrahi, V., Lazarus, G.M., Miles, L.M., Meyers, C.A. and Debouck, C. (1989) Recombinant HIV-1 reverse transcriptase: purification, primary structure and polymerase/ribonuclease H activities. Arch. Biochem. Biophys. 273, 347-358.
27. Müller, B., Restle, T., Weiss, S., Gautel, M., Sczakiel, G. and Goody, R.S. (1989) Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in E.coli. J. Biol. Chem. 264, 1375-1378.
28. Nanni, R.G., Ding, J., Jacobo-Molina, A., Hughes, S.H. and Arnold, E. (1993) Review of HIV-1 reverse transcriptase three-dimensional structure: Implications for drug design. Perspect. Drug Discovery Design 1, 129-150.
29. Pauwels, R., Andries, K., Desmyter, J. et al. (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343, 470-474.
30. Smerdon, S.J., Jäger, J., Wang, J. et al. (1994) Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91, 3911-3915.
31. Stammers, D.K., Ross, C.K., Idriss, H. and Lowe, D.M. (1992) Formation of heterodimers of HIV-1 reverse transcriptase by recombination of separately purified subunits. Eur. J. Biochem. 206, 437-440.
32. Starnes, M.C. and Cheng, Y.-C. (1989) Human immunodeficiency virus reverse transcriptase-associated RNase H activity. J. Biol. Chem. 264, 7073-7077.
33. Tantillo, C., Ding, J., Jacobo-Molina, A. et al. (1994) Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. J. Mol. Biol. 243, 369-387.